Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2018 1
2019 2
2021 1
2022 1
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Adalimumab in Pediatric Ulcerative Colitis: A Real-life Experience from the SIGENP-IBD Registry.
Aloi M, Bramuzzo M, Arrigo S, Romano C, D'Arcangelo G, Lacorte D, Gatti S, Illiceto MT, Zucconi F, Dilillo D, Zuin G, Knafelz D, Ravelli A, Cucchiara S, Alvisi P; SIGENP IBD Working Group. Aloi M, et al. J Pediatr Gastroenterol Nutr. 2018 Jun;66(6):920-925. doi: 10.1097/MPG.0000000000001883. J Pediatr Gastroenterol Nutr. 2018. PMID: 29315163
Efficacy and safety of infliximab in very early onset inflammatory bowel disease: a national comparative retrospective study.
Bramuzzo M, Arrigo S, Romano C, Filardi MC, Lionetti P, Agrusti A, Dipasquale V, Paci M, Zuin G, Aloi M, Strisciuglio C, Miele E, Pastore M, Martelossi S, Alvisi P; SIGENP IBD Working Group. Bramuzzo M, et al. United European Gastroenterol J. 2019 Jul;7(6):759-766. doi: 10.1177/2050640619847592. Epub 2019 Apr 25. United European Gastroenterol J. 2019. PMID: 31316780 Free PMC article.
Epidemiological trends of pediatric IBD in Italy: A 10-year analysis of the Italian society of pediatric gastroenterology, hepatology and nutrition registry.
Alvisi P, Labriola F, Scarallo L, Gandullia P, Knafelz D, Bramuzzo M, Zuin G, Pastore MR, Illiceto MT, Miele E, Graziano F, Romano C, Bartoletti D, Oliva S, Arrigo S, Bracci F, Renzo S, Agrusti A, Aloi M, Lionetti P; SIGENP IBD Working Group. Alvisi P, et al. Dig Liver Dis. 2022 Apr;54(4):469-476. doi: 10.1016/j.dld.2021.12.018. Epub 2022 Feb 4. Dig Liver Dis. 2022. PMID: 35125313
Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.
Aloi M, DʼArcangelo G, Bramuzzo M, Gasparetto M, Martinelli M, Alvisi P, Illiceto MT, Valenti S, Distante M, Pellegrino S, Gatti S, Arrigo S, Civitelli F, Martelossi S; SIGENP IBD Working Group. Aloi M, et al. Inflamm Bowel Dis. 2016 Jul;22(7):1647-54. doi: 10.1097/MIB.0000000000000828. Inflamm Bowel Dis. 2016. PMID: 27271489
Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn's disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience.
Alvisi P, Arrigo S, Cucchiara S, Lionetti P, Miele E, Romano C, Ravelli A, Knafelz D, Martelossi S, Guariso G, Accomando S, Zuin G, De Giacomo C, Balzani L, Gennari M, Aloi M; SIGENP IBD Working Group. Alvisi P, et al. Biologics. 2019 Jan 3;13:13-21. doi: 10.2147/BTT.S183088. eCollection 2019. Biologics. 2019. PMID: 30655661 Free PMC article.